TIL
Instil Bio, Inc.
Key Financials
Revenue
$0
↓ 100.0%
Net Income
$-71372000
↑ 3.7%
Operating Income
$-78581000
↓ 6.9%
Total Liabilities
$89.7M
↓ 4.8%
EPS (Diluted)
$-10.70
↑ 6.1%
Shareholders' Equity
$113.9M
↓ 32.8%
Total Assets
$203.5M
↓ 22.8%
Cash & Equivalents
$6.6M
↓ 24.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 8-K | 6/11/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| ARS | 4/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TIL |
| Company Name | Instil Bio, Inc. |
| CIK | 1789769 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NY |
| Phone | (972) 499-3350 |